Prot# 021-003: A Phase 2, Multicenter, Open-Label Case-Controlled(Part 1), Rndmzd, Active-Controlled(Part 2)Study of AQ4N, in Comb w/Radiotherapy & Temozolomide, for Safety, Tolerability, & Activity in Sbjts w/Newly Diagnosed Glioblastoma Multiforme

Project: Research project

Project Details

StatusFinished
Effective start/end date2/22/079/1/11

Funding

  • Novacea, Inc. (021-003)